Physician

Mohamed S Ali, M.D.

According to 2025 Medicare claims, Mohamed Ali, M.D. (NPI: 1881705580) practices internal medicine in the Bay City, MI market, with the plurality of this provider's patient population coming from Bay, MI. This provider's primary affiliated billing organization is MCLAREN MEDICAL GROUP (NPI: 1346396066; TIN: 38-2988086) and primary practice location at 48706-2844. Ali is affiliated with the McLaren High Performance Network, LLC (ACO ID: A3317) and Mosaic ACO (ACO ID: A5033), participating under the MSSP model.

Ali's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,258 traditional Medicare patients, billed 4,561 HCPCS/CPT codes, and received $191,322 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 15,122 prescription claims across 900 beneficiaries totaling $1,768,698 in drug costs, led by Mounjaro (Tirzepatide). DME data shows 308 claims. Open Payments data shows 36 records totaling $702. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing started with an early spike, then settled into a lower baseline, moving from $658,347 to $191,322. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $40,522 and ending at $21,658.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,008	9,523	$658,347
2016	1,042	8,824	$626,506
2017	764	5,507	$367,700
2018	634	2,552	$154,453
2019	835	4,095	$284,895
2020	685	3,523	$249,059
2021	721	3,328	$275,110
2022	531	2,832	$222,662
2023	946	3,289	$209,917
2024	1,258	4,561	$191,322

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	776	14,510	$1,210,454
2016	825	14,632	$1,229,763
2017	769	15,835	$1,308,123
2018	735	13,979	$1,277,507
2019	727	11,166	$1,038,766
2020	679	11,545	$1,105,211
2021	691	10,446	$1,063,621
2022	698	8,603	$998,212
2023	799	12,685	$1,547,166
2024	900	15,122	$1,768,698

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	290	974	$42,062
2016	290	954	$32,851
2017	332	938	$25,237
2018	311	1,045	$32,103
2019	238	966	$25,618
2020	176	661	$21,390
2021	103	551	$24,175
2022	106	460	$21,408
2023	74	374	$20,569
2024	33	308	$12,870

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	188	188	$132
99239	Hospital discharge day management, more than 30 minutes	56	59	$92
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	266	925	$82
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	188	715	$63
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	873	1,149	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Mounjaro	Tirzepatide	191	6,585	$236,134
Ozempic	Semaglutide	162	6,836	$215,809
Eliquis	Apixaban	198	10,571	$202,967
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	200	8,520	$174,116
Synjardy	Empagliflozin/Metformin Hcl	58	3,700	$70,728

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	77	$5,374
A7034	Nasal interface (mask or cannula type) used with positive airway pressure device, with or without head strap	N	N/R	26	$1,517
A7033	Pillow for use on nasal cannula type interface, replacement only, pair	N	N/R	14	$1,310
A7032	Cushion for use on nasal mask interface, replacement only, each	N	N/R	12	$1,288
A4604	Tubing with integrated heating element for use with positive airway pressure device	N	N/R	22	$904

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	36	$702	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Mohamed S. Ali, M.D.?

Tedicare shows public-source Medicare data for Mohamed S. Ali, M.D. (NPI 1881705580), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mohamed S. Ali, M.D. have ACO affiliation data?

Mohamed S. Ali, M.D. is shown with ACO affiliation data for McLaren High Performance Network, LLC (MSSP, ACO ID A3317) and Mosaic ACO (MSSP, ACO ID A5033).

What billing organization is linked to Mohamed S. Ali, M.D.?

Mohamed S. Ali, M.D. is linked to MCLAREN MEDICAL GROUP (billing NPI 1346396066) in the available physician profile data.

Does Mohamed S. Ali, M.D. have Open Payments data?

Mohamed S. Ali, M.D. has 36 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.